What is Eton Pharmaceuticals, Inc.'s D&A?

Eton Pharmaceuticals, Inc. (ETON) reported D&A of $1.13M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s D&A changed year-over-year?

Eton Pharmaceuticals, Inc.'s D&A increased by 11.6% year-over-year, from $1.01M to $1.13M.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s D&A?

Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s D&A has grown at a 72.0% compound annual growth rate (CAGR), from $462K to $4.04M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Eton Pharmaceuticals, Inc. ETON D&A

D&A at other companies

HRO

HarrowHROW

$455K-2.2%

Zevra Therapeutics, Inc.ZVRA

$368K-77.7%

XER

Xeris Biopharma Holdings, Inc.XERS

$337K+7.0%

Ultragenyx PharmaceuticalRARE

$8M-11.1%

ANI PharmaceuticalsANIP

$20.92M-8.6%

Crinetics PharmaceuticalsCRNX

$1.16M+25.4%

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s D&A?: Eton Pharmaceuticals, Inc. (ETON) reported D&A of $1.13M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s D&A changed year-over-year?: Eton Pharmaceuticals, Inc.'s D&A increased by 11.6% year-over-year, from $1.01M to $1.13M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s D&A?: Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s D&A has grown at a 72.0% compound annual growth rate (CAGR), from $462K to $4.04M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.